Patents by Inventor Luigi Lay

Luigi Lay has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Carbocyclic derivatives and conjugated derivatives thereof, and their use in vaccines
    Patent number: 12702705
    Abstract: The invention is in the field of vaccines and relates to oligomers having a selected degree of polymerization, obtained by connecting together a number of carbocyclic repeating units, and to conjugated derivatives thereof. The oligomers and conjugated derivatives thereof of the invention also have a selected degree of acetylation. The derivatives of the invention are useful for the preparation of immunogenic compositions, e.g. in the form of a vaccine.
    Type: Grant
    Filed: March 6, 2020
    Date of Patent: August 11, 2026
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Roberto Adamo, Francesco Berti, Paolo Costantino, Luigi Lay
  • CARBOCYCLIC DERIVATIVES AND CONJUGATED DERIVATIVES THEREOF, AND THEIR USE IN VACCINES
    Publication number: 20220152183
    Abstract: The invention is in the field of vaccines and relates to oligomers having a selected degree of polymerization, obtained by connecting together a number of carbocyclic repeating units, and to conjugated derivatives thereof. The oligomers and conjugated derivatives thereof of the invention also have a selected degree of acetylation. The derivatives of the invention are useful for the preparation of immunogenic compositions, e.g. in the form of a vaccine.
    Type: Application
    Filed: March 6, 2020
    Publication date: May 19, 2022
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Roberto ADAMO, Francesco BERTI, Paolo COSTANTINO, Luigi LAY
  • COMPOUNDS
    Publication number: 20130315959
    Abstract: The invention provides a synthetic C. difficile PS-II cell wall saccharide. The invention also provides a process for purifying C. difficile PS-II saccharide from C. difficile bacterial cells resulting in reduced contamination. The saccharides may be used in vaccines, particularly as conjugates with carrier proteins.
    Type: Application
    Filed: December 23, 2011
    Publication date: November 28, 2013
    Applicant: NOVARTIS AG
    Inventors: Paolo Costantino, Roberto Adamo, Maria Rosaria Romano, Elisa Danieli, Francesco Berti, Emilia Cappelliti, Luigi Lay